- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Cancellous bone.
Displaying page 1 of 1.
EudraCT Number: 2015-003638-28 | Sponsor Protocol Number: 2015/576 | Start Date*: 2015-09-30 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital | ||||||||||||||||||
Full Title: ALOSTRA Alendronate treatment of osteoporosis in rheumatoid arthritis – indication and duration. A randomized, doubleblind, placebocontrolled multi-centre study to evaluate the effects of disconti... | ||||||||||||||||||
Medical condition: Rheumatoid arthritis and osteoporosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000515-95 | Sponsor Protocol Number: B3D-EW-GHCX | Start Date*: 2005-06-16 |
Sponsor Name:Eli Lilly and Company Limited | ||
Full Title: Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women with Osteoporosis: A Histomorphometric Study | ||
Medical condition: Osteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: CZ (Completed) ES (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002642-23 | Sponsor Protocol Number: NVD-CLN01 | Start Date*: 2016-11-28 |
Sponsor Name:Novadip Biosciences | ||
Full Title: A prospective multi-centre, randomised, controlled study to evaluate the safety and preliminary effectiveness of NVD-001 for the treatment of low grade degenerative lumbar spondylolisthesis by inte... | ||
Medical condition: Patients diagnosed with symptomatic degenerative spondylolisthesis grade I or II with an indication for spinal fusion of one vertebral segment (L1-S1). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) PL (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000258-12 | Sponsor Protocol Number: 230189 | Start Date*: 2014-10-15 | |||||||||||
Sponsor Name:Orthopedic Research in Aarhus | |||||||||||||
Full Title: Pharmacokinetics of vancomycin in cancellous and cortical bone obtained by microdialysis | |||||||||||||
Medical condition: Orthopedic infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005581-39 | Sponsor Protocol Number: CL3-12911-025 | Start Date*: 2007-04-02 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bo... | |||||||||||||
Medical condition: Treatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fractures | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) HU (Completed) NL (Completed) CZ (Completed) IT (Completed) DK (Completed) EE (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015939-33 | Sponsor Protocol Number: 20080394 | Start Date*: 2010-03-23 |
Sponsor Name:Amgen Inc | ||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults with Fresh Unilateral Intertrochanteric Fracture of the P... | ||
Medical condition: Acceleration of fracture healing | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: FR (Completed) GB (Completed) DE (Completed) SE (Completed) PL (Completed) DK (Completed) NL (Completed) LV (Completed) GR (Completed) IT (Completed) HU (Completed) BE (Completed) FI (Completed) LT (Completed) EE (Completed) BG (Completed) SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001116-65 | Sponsor Protocol Number: B3D-MC-GHDQ | Start Date*: 2012-02-10 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Second study on the Effect of Teriparatide on Femoral Neck Fracture Healing | |||||||||||||
Medical condition: Low trauma femoral neck fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) GR (Completed) PL (Completed) NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
